TERBUTALINE SULFATE tablet United States - English - NLM (National Library of Medicine)

terbutaline sulfate tablet

lannett company, inc. - terbutaline sulfate (unii: 576pu70y8e) (terbutaline - unii:n8onu3l3pg) - terbutaline sulfate 2.5 mg - terbutaline sulfate is indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema. 1. tocolysis oral terbutaline sulfate has not been approved and should not be used for acute or maintenance tocolysis [see boxed warning: tocolysis ]. 2. hypersensitivity terbutaline sulfate is contraindicated in patients known to be hypersensitive to sympathomimetic amines or any component of this drug product.

TERBUTALINE SULFATE injection United States - English - NLM (National Library of Medicine)

terbutaline sulfate injection

medical purchasing solutions. llc - terbutaline sulfate (unii: 576pu70y8e) (terbutaline - unii:n8onu3l3pg) - terbutaline sulfate 1 mg in 1 ml - terbutaline sulfate injection, usp is indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema. 1. prolonged tocolysis terbutaline sulfate has not been approved and should not be used for prolonged tocolysis (beyond 48-72 hours). in particular, terbutaline sulfate should not be used for maintenance tocolysis in the outpatient or home setting (see boxed warning: prolonged tocolysis ). 2. hypersensitivity terbutaline sulfate injection is contraindicated in patients known to be hypersensitive to sympathomimetic amines or any component of this drug product.

TERBUTALINE SULFATE injection United States - English - NLM (National Library of Medicine)

terbutaline sulfate injection

akorn - terbutaline sulfate (unii: 576pu70y8e) (terbutaline - unii:n8onu3l3pg) - terbutaline sulfate 1 mg in 1 ml - terbutaline sulfate injection, usp is indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema. terbutaline sulfate has not been approved and should not be used for prolonged tocolysis (beyond 48 -72 hours). in particular, terbutaline sulfate should not be used for maintenance tocolysis in the outpatient or home setting. [see boxed warning, prolonged tocolysis .] terbutaline sulfate injection is contraindicated in patients known to be hypersensitive to sympathomimetic amines or any component of this drug product.

TEXALIN SYRUP Kenya - English - Pharmacy and Poisons Board

texalin syrup

surgilinks ltd surgilinks building, mombasa road - terbutaline sulphate bp, bromhexine hydrochloride… - syrup - terbutaline sulphate bp 2.5mg, bromhexine… - terbutaline combinations

BRO-ZEDEX 1.25MG+ 4 MG+50 MG+2.5 MG/5 ML ORAL LIQUID ORDINARY SYRUPS Uganda - English - National Drug Authority

bro-zedex 1.25mg+ 4 mg+50 mg+2.5 mg/5 ml oral liquid ordinary syrups

wockhardt ltd - terbutaline sulphate +bromhexine hydrochloride+guaiphenesin+menthol - oral liquid ordinary syrups - 1.25mg+ 4 mg+50 mg+2.5 mg/5 ml

TERBUTALINE SULFATE tablet United States - English - NLM (National Library of Medicine)

terbutaline sulfate tablet

state of florida doh central pharmacy - terbutaline sulfate (unii: 576pu70y8e) (terbutaline - unii:n8onu3l3pg) - terbutaline sulfate 2.5 mg - terbutaline sulfate is indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema. terbutaline sulfate is contraindicated in patients known to be hypersensitive to sympathomimetic amines or any component of this drug product.

TERBUTALINE SULFATE injection, solution United States - English - NLM (National Library of Medicine)

terbutaline sulfate injection, solution

general injectables & vaccines, inc - terbutaline sulfate (unii: 576pu70y8e) (terbutaline - unii:n8onu3l3pg) - terbutaline sulfate 1 mg in 1 ml - terbutaline sulfate injection, usp is indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema. prolonged tocolysis terbutaline sulfate has not been approved and should not be used for prolonged tocolysis (beyond 48 to 72 hours). in particular, terbutaline sulfate should not be used for maintenance tocolysis in the outpatient or home setting (see boxed warning: prolonged tocolysis). hypersensitivity terbutaline sulfate injection is contraindicated in patients known to be hypersensitive to sympathomimetic amines or any component of this drug product.

CUF- FREE SYRUP Kenya - English - Pharmacy and Poisons Board

cuf- free syrup

national pharmacy ltd 17843-0500, sclaters house, parkalands road. - terbutaline sulphate1.25mg,bromhexine hcl… - syrup - terbutaline sulphate1.25mg,bromhexine hcl… - cough suppressants and expectorants combinations:

TERBUTALINE SULFATE tablet United States - English - NLM (National Library of Medicine)

terbutaline sulfate tablet

pd-rx pharmaceuticals, inc. - terbutaline sulfate (unii: 576pu70y8e) (terbutaline - unii:n8onu3l3pg) - terbutaline sulfate 5 mg

TERBUTALINE SULFATE tablet United States - English - NLM (National Library of Medicine)

terbutaline sulfate tablet

marlex pharmaceuticals inc - terbutaline sulfate (unii: 576pu70y8e) (terbutaline - unii:n8onu3l3pg) - terbutaline sulfate is indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema. oral terbutaline sulfate has not been approved and should not be used for acute or maintenance tocolysis. [see boxed warning: tocolysis .] terbutaline sulfate is contraindicated in patients known to be hypersensitive to sympathomimetic amines or any component of this drug product.